Chronic HIV infection is associated with upregulation of proinflammatory cytokine and chemokine and alpha defensin gene expression in colorectal mucosa

AIDS Research and Human Retroviruses

Volumn 31, Issue 6, 2015, Pages 615-622

  Mait Kaufman, Jennifer ^a   Fakioglu, Esra ^a   Mesquita, Pedro M M ^a   Elliott, Julie ^b   Lo, Yungtai ^a   Madan, Rebecca Pellett ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; BETA DEFENSIN 1; BETA DEFENSIN 2; BETA DEFENSIN 5; CHEMOKINE; CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; TOLL LIKE RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; COLON BIOPSY; CONTROLLED STUDY; COPY NUMBER VARIATION; DIGESTIVE SYSTEM INFLAMMATION; DOWN REGULATION; FEMALE; GASTROINTESTINAL MUCOSA; GENE EXPRESSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOREGULATION; LONG TERMINAL REPEAT; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; ULCERATIVE COLITIS; UPREGULATION; VIRUS LOAD; BIOPSY; BIOSYNTHESIS; CHRONIC DISEASE; COLON; GENE EXPRESSION PROFILING; GENETICS; IMMUNOLOGY; INTESTINE MUCOSA; MIDDLE AGED; PATHOLOGY; RECTUM;

ADULT; ALPHA-DEFENSINS; BIOPSY; CHRONIC DISEASE; COLON; CYTOKINES; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HIV INFECTIONS; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RECTUM; UP-REGULATION;

EID: 84930252330     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2014.0085     Document Type: Article

References (39)

1. Olsson J, Poles M, Spetz AL, et al.: Human immunodeficiency virus type 1 infection is associated with significant mucosal inflammation characterized by increased expression of CCR5, CXCR4, and beta-chemokines. J Infect Dis 2000;182(6):1625-1635.
2. Sankaran S, George MD, Reay E, et al.: Rapid onset of intestinal epithelial barrier dysfunction in primary human immunodeficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration. J Virol 2008;82(1):538-545.
3. McGowan I, Elliott J, Cortina G, et al.: Characterization of baseline intestinal mucosal indices of injury and inflammation in men for use in rectal microbicide trials (HIV Prevention Trials Network-056). J Acquir Immune Defic Syndr 2007;46(4):417-425.
4. McGowan I, Radford-Smith G, and Jewell DP: Cytokine gene expression in HIV-infected intestinal mucosa. AIDS 1994;8(11):1569-1575.
5. McGowan I, Elliott J, Fuerst M, et al.: Increased HIV-1 mucosal replication is associated with generalized mucosal cytokine activation. J Acquir Immune Defic Syndr 2004;37(2):1228-1236.
6. Epple HJ, Schneider T, Troeger H, et al.: Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV-infected patients. Gut 2009;58(2): 220-227.
7. Verhoeven D, Sankaran S, Silvey M, and Dandekar S: Antiviral therapy during primary simian immunodeficiency virus infection fails to prevent acute loss of CD4 + T cells in gut mucosa but enhances their rapid restoration through central memory T cells. J Virol 2008;82(8):4016-4027.
8. Brenchley JM and Douek DC: HIV infection and the gastrointestinal immune system. Mucosal Immunol 2008; 1(1):23-30.
9. Kinugasa T, Akagi Y, Yoshida T, et al.: Increased claudin-1 protein expression contributes to tumorigenesis in ulcerative colitis-associated colorectal cancer. Anticancer Res 2010;30(8):3181-3186.
10. Estes JD, Harris LD, Klatt NR, et al.: Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS Pathog 2010;6(8):e1001052.
11. Epple HJ, Allers K, Troger H, et al.: Acute HIV infection induces mucosal infiltration with CD4 + and CD8 + T cells, epithelial apoptosis, and a mucosal barrier defect. Gastroenterology 2010;139(4):1289-1300.
12. Sandler NG and Douek DC: Microbial translocation in HIV infection: Causes, consequences and treatment opportunities. Nat Rev Microbiol 2012;10(9):655-666.
13. Brenchley JM and Douek DC: The mucosal barrier and immune activation in HIV pathogenesis. Curr Opin HIV AIDS 2008;3(3):356-361.
14. Suzuki T, Yoshinaga N, and Tanabe S: Interleukin-6 (IL-6) regulates claudin-2 expression and tight junction permeability in intestinal epithelium. J Biol Chem 2011;286(36): 31263-31271.
15. Swidsinski A, Ladhoff A, Pernthaler A, et al.: Mucosal flora in inflammatory bowel disease. Gastroenterology 2002;122(1):44-54.
16. d'Ettorre G, Paiardini M, Zaffiri L, et al.: HIV persistence in the gut mucosa of HIV-infected subjects undergoing antiretroviral therapy correlates with immune activation and increased levels of LPS. Curr HIV Res 2011;9(3): 148-153.
17. Wehkamp J, Harder J, Weichenthal M, et al.: Inducible and constitutive beta-defensins are differentially expressed in Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 2003;9(4):215-223.
18. Wehkamp J, Harder J, Weichenthal M, et al.: NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut 2004;53(11):1658-1664.
19. Brenchley JM, Price DA, Schacker TW, et al.: Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006;12(12):1365-1371.
20. Stanislawowski M, Wierzbicki PM, Golab A, et al.: Decreased Toll-like receptor-5 (TLR-5) expression in the mucosa of ulcerative colitis patients. J Physiol Pharmacol 2009;60(Suppl 4):71-75.
21. Zaragoza MM, Sankaran-Walters S, Canfield DR, et al.: Persistence of gut mucosal innate immune defenses by enteric alpha-defensin expression in the simian immunodeficiency virus model of AIDS. J Immunol 2011;186(3): 1589-1597.
22. Klatt NR, Funderburg NT, and Brenchley JM: Microbial translocation, immune activation, and HIV disease. Trends Microbiol 2013;21(1):6-13.
23. Geboes K, Riddell R, Ost A, et al.: A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut 2000;47(3):404-409.
24. Folks TM, Justement J, Kinter A, et al.: Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science 1987;238(4828):800-802.
25. Mesquita PM, Rastogi R, Segarra TJ, et al.: Intravaginal ring delivery of tenofovir disoproxil fumarate for prevention of HIV and herpes simplex virus infection. J Antimicrob Chemother 2012;67(7):1730-1738.
26. Schulbin H, Bode H, Stocker H, et al.: Cytokine expression in the colonic mucosa of human immunodeficiency virusinfected individuals before and during 9 months of antiretroviral therapy. Antimicrob Agents Chemother 2008; 52(9):3377-3384.
27. Poli G, Bressler P, Kinter A, et al.: Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms. J Exp Med 1990;172(1):151-158.
28. Lane BR, Lore K, Bock PJ, et al.: Interleukin-8 stimulates human immunodeficiency virus type 1 replication and is a potential new target for antiretroviral therapy. J Virol 2001;75(17):8195-8202.
29. Haase AT: Targeting early infection to prevent HIV-1 mucosal transmission. Nature 2010;464(7286):217-223.
30. Quinones-Mateu ME, Lederman MM, Feng Z, et al.: Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication. AIDS 2003;17(16):F39-48.
31. Zapata W, Rodriguez B, Weber J, et al.: Increased levels of human beta-defensins mRNA in sexually HIV-1 exposed but uninfected individuals. Curr HIV Res 2008;6(6):531-538.
32. Bevins CL and Salzman NH: Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis. Nat Rev Microbiol 2011;9(5):356-368.
33. Selsted ME and Ouellette AJ: Mammalian defensins in the antimicrobial immune response. Nat Immunol 2005;6(6): 551-557.
34. Porter E, Yang H, Yavagal S, et al.: Distinct defensin profiles in Neisseria gonorrhoeae and Chlamydia trachomatis urethritis reveal novel epithelial cell-neutrophil interactions. Infect Immun 2005;73(8):4823-4833.
35. Wilson SS, Wiens ME, and Smith JG: Antiviral mechanisms of human defensins. J Mol Biol 2013;425(24):4965-4980.
36. Morson B: Rectal and colonic biopsy in inflammatory bowel disease. Am J Gastroenterol 1977;67(5):417-426.
37. Surawicz CM and Belic L: Rectal biopsy helps to distinguish acute self-limited colitis from idiopathic inflammatory bowel disease. Gastroenterology 1984;86(1):104-113.
38. Jenkins D, Balsitis M, Gallivan S, et al.: Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative. J Clin Pathol 1997;50(2):93-105.
39. Jarchum I, Liu M, Shi C, et al.: Critical role for MyD88-mediated neutrophil recruitment during Clostridium difficile colitis. Infect Immun 2012;80(9):2989-2996.